The Deeley Research Centre (DRC) is a key site for BC Cancer’s Immunotherapy ProgramResearchers at the DRC are studying how the immune system responds to cancer and how best to enhance this response for therapeutic purposes. The Immunotherapy Program is translating discoveries from the DRC and our many collaborators into innovative clinical trials, offering promising new treatment options for patients with cancer.

Thanks to generous support of the Conconi family and thousands of other donors to the BC Cancer Foundation, as well as grants from the Canada Foundation for Innovation and the BC Knowledge Development Fund, the DRC is home to the Conconi Family Immunotherapy Lab (CFIL). CFIL is an advanced cell manufacturing facility that produces natural and genetically engineered T cell products for clinical trials in BC and other sites in Canada.

The DRC is also home to the Molecular and Cellular Immunology Core, and supports BC Cancer’s Biobanking and Biospecimen Research Services.

BC Cancer's Immunotherapy Program

The BC Cancer’s Immunotherapy Program's goal is to develop precise and potent immunotherapeutic strategies for cancer. With the generous support of the Conconi family, donors and the BCCF the DRC constructed the Conconi Family Immunotherapy Lab (CFIL). CFIL is and advanced GMP cell therapy manufacturing facility that supports the production of cellular products for immunotherapy clinical trials.   

Learn more about BC Cancer's Immunotherapy Program

Xavier Pelletier High School Internship Program

The DRC offers Grade 11 high school students a first-hand opportunity to explore cancer research. Under the guidance of DRC researchers, the students take on their own 8-week research project using the latest laboratory techniques to fight cancer.

Research Labs & Principal Investigators

Leadership

News & Events

BC Cancer researchers receive Cancer Research Society’s Doctoral Research Awards

BC Cancer researchers receive Cancer Research Society’s Doctoral Research Awards

Three BC Cancer graduate students are 2024 recipients of Doctoral Research Awards from the Cancer Research Society (CRS), receiving new funding to support their innovative research aimed at better understanding cancer.

Doctoral Research Awards recipients 

Doctoral Research Awards invests in the future of cancer research through the support of graduate students pursuing cancer research at an eligible Canadian institution.

Two BC Cancer research teams awarded in 2024 competition for prestigious Terry Fox New Frontiers Program Project Grants

Two BC Cancer research teams are 2024 recipients of the Terry Fox New Frontiers Program Project Grants (PPG), receiving new and renewal funding to advance cancer research and improve treatments. 

Project: Integrated Immunotherapy for Ovarian Cancer

One of this year’s newly funded teams is based in Victoria and led by Dr. Brad Nelson. 

BC Cancer 2024 Summer Research Studentship Awards Announced

BC Cancer 2024 Summer Research Studentship competition, sponsored by the BC Cancer Foundation, supports senior undergraduate university students and/or junior medical or dental students seeking hands-on training in cancer research in British Columbia. These summer studentships may address any discipline of cancer research including clinical, translational, basic, behavioural and population research areas.

The 2024 awardees are:

Back to top